Stay updated on IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.

Latest updates to the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a minor page update. No study details or participant information were changed.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check46 days agoChange DetectedThe page now displays a new revision tag, v3.6.4, replacing the previous v3.6.3. This indicates a minor update to the page version.SummaryDifference0.0%

- Check53 days agoChange DetectedA new Publications entry for five-year survival with tebentafusp in metastatic uveal melanoma was added to Publications, and the previously listed entry for the same article was removed.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing Revision: v3.6.1. This indicates a minor system update to the page rendering rather than a modification of the study details.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.1 for the page, reflecting a minor release of the site software. This appears to be an internal update rather than a change to the study text or data.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page now shows recruitment has closed and includes new guidance sections to help readers understand the study record and enrollment process.SummaryDifference0.3%

Stay in the know with updates to IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.